NEWS9 February 2010
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
US— IMS Health shareholders have voted to approve the healthcare researcher’s $5bn takeover by investment groups TPG Capital and the CCP Investment Board.
More than 75% of stockholders backed the deal, which will see them receive $22 a share.
TPG Capital and the CCP Investment Board made their move to buy IMS last November following speculation that the firm was the target of a private equity buy-out.
The deal is still subject to the satisfaction or waiver of certain other closing conditions, but is expected to be completed during the first quarter of 2010. The takeover cleared all antitrust hurdles last week.
IMS, which is headed by CEO David Carlucci (pictured), came close to being bought by VNU (now The Nielsen Company) in 2005 but the deal fell through when VNU shareholders opposed it.
Newsletter
Sign up for the latest news and opinion.
You will be asked to create an account which also gives you free access to premium Impact content.
Cynozure bolsters US team https://t.co/eXWTCHXiKx #mrx #marketresearch
Behaviorally develops qual offer https://t.co/OZRVHgGQ1Q #mrx #marketresearch
UK profit warnings rise by 50% https://t.co/8acEcvOIlM #mrx #marketresearch
LAUNCHED Digital Ethnography 2023 23/03/23 9:30-16:35 ℹ️ Info + ticket: https://t.co/h3nN451Fgi Join us to ga… https://t.co/svXukMaxbS
The post-demographic consumerism trend means segments such age are often outdated, from @trendwatching #TrendSemLON
0 Comments